These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16062087)

  • 21. Doxorubicin/methotrexate/fluorouracil in advanced pancreatic cancer.
    Porta C; Nastasi G; Spaghi A; Moroni M
    Lancet; 1990 Dec; 336(8728):1454-5. PubMed ID: 1978920
    [No Abstract]   [Full Text] [Related]  

  • 22. [Asymptomatic multinodular liver disease].
    Cadiot G
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B154-8. PubMed ID: 12843952
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
    Nocera M; Baudin E; Pellegriti G; Cailleux AF; Mechelany-Corone C; Schlumberger M
    Br J Cancer; 2000 Sep; 83(6):715-8. PubMed ID: 10952773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
    Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
    Dtsch Med Wochenschr; 2004 Mar; 129(13):689-92. PubMed ID: 15026965
    [No Abstract]   [Full Text] [Related]  

  • 26. Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial.
    Ducreux M; Dahan L; Smith D; O'Toole D; Lepère C; Dromain C; Vilgrain V; Baudin E; Lombard-Bohas C; Scoazec JY; Seitz JF; Bitoun L; Koné S; Mitry E
    Eur J Cancer; 2014 Dec; 50(18):3098-106. PubMed ID: 25454412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonsurgical treatment of advanced malignant neuroendocrine pancreatic tumors and midgut carcinoids.
    Skogseid B
    World J Surg; 2001 Jun; 25(6):700-3. PubMed ID: 11376401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine tumours of the gastrointestinal tract: Chemotherapy.
    Arnold R; Rinke A; Schmidt Ch; Hofbauer L
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):649-56. PubMed ID: 16183533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation and chemotherapy. Treatment of localized pancreatic carcinoma.
    Blitzer PH; Dosoretz DE; Katin MJ; Rubenstein JH; Harwin WN; Raymond MG; Teufel TE; Seidenstein L; Mangano MM; Salenius SA
    J Fla Med Assoc; 1994 Jun; 81(6):403-7. PubMed ID: 8064281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
    Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
    Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
    [No Abstract]   [Full Text] [Related]  

  • 31. Gut neuroendocrine tumors.
    Hammond PJ; Bloom SR
    Curr Ther Endocrinol Metab; 1994; 5():570-5. PubMed ID: 7704795
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chemotherapy of pancreatic cancer is not yet generally recommended].
    Hartwich G
    Med Klin; 1980 Aug; 75(16):575-9. PubMed ID: 6447832
    [No Abstract]   [Full Text] [Related]  

  • 33. Response to doxorubicin/methotrexate/fluorouracil in advanced adenocarcinoma of pancreas or biliary tract.
    Pyrhönen S; Valtonen M
    Lancet; 1990 Jul; 336(8707):127. PubMed ID: 1975317
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy for pancreatic carcinoma.
    Kao GD
    Lancet; 1991 Jan; 337(8734):177. PubMed ID: 1670814
    [No Abstract]   [Full Text] [Related]  

  • 35. Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma.
    Karatas F; Sahin S; Aytekin A; Hacioglu MB; Imamoglu GI; Altinbas M
    J Cancer Res Ther; 2018; 14(5):1149-1151. PubMed ID: 30197367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy for advanced gastric carcinoma.
    JAMA; 1986 Jan; 255(3):321-3. PubMed ID: 3753616
    [No Abstract]   [Full Text] [Related]  

  • 37. A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
    Frame J; Kelsen D; Kemeny N; Cheng E; Niedzwiecki D; Heelan R; Lippermann R
    Am J Clin Oncol; 1988 Aug; 11(4):490-5. PubMed ID: 2841843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferons alone or in combination with chemotherapy or other biologicals in the treatment of neuroendocrine gut and pancreatic tumors.
    Oberg K; Eriksson B; Janson ET
    Digestion; 1994; 55 Suppl 3():64-9. PubMed ID: 7698540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pancreatic islet cell carcinoma with multiple hepatic metastases successfully treated with a streptozocin/5-FU regimen--a case report].
    Arakawa Y; Mizunuma N; Aiba K; Ito Y; Takahashi S; Irie T; Watanabe J; Tada K; Okudaira T; Seki M; Yamaguchi T; Muto T; Hatake K
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2561-4. PubMed ID: 12506483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment strategy of neuroendocrine tumors].
    Ducreux M; Baudin E; Schlumberger M
    Rev Prat; 2002 Feb; 52(3):290-6. PubMed ID: 11925720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.